Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2059447
Max Phase: Preclinical
Molecular Formula: C24H23NO3S
Molecular Weight: 405.52
Molecule Type: Small molecule
Associated Items:
ID: ALA2059447
Max Phase: Preclinical
Molecular Formula: C24H23NO3S
Molecular Weight: 405.52
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC1(C)C=Cc2cc(CN(c3ccccc3)S(=O)(=O)c3ccccc3)ccc2O1
Standard InChI: InChI=1S/C24H23NO3S/c1-24(2)16-15-20-17-19(13-14-23(20)28-24)18-25(21-9-5-3-6-10-21)29(26,27)22-11-7-4-8-12-22/h3-17H,18H2,1-2H3
Standard InChI Key: RMVXJZBJMUPCEH-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 405.52 | Molecular Weight (Monoisotopic): 405.1399 | AlogP: 5.27 | #Rotatable Bonds: 5 |
Polar Surface Area: 46.61 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 5.31 | CX LogD: 5.31 |
Aromatic Rings: 3 | Heavy Atoms: 29 | QED Weighted: 0.58 | Np Likeness Score: -0.26 |
1. Mun J, Jabbar AA, Devi NS, Liu Y, Van Meir EG, Goodman MM.. (2012) Structure-activity relationship of 2,2-dimethyl-2H-chromene based arylsulfonamide analogs of 3,4-dimethoxy-N-[(2,2-dimethyl-2H-chromen-6-yl)methyl]-N-phenylbenzenesulfonamide, a novel small molecule hypoxia inducible factor-1 (HIF-1) pathway inhibitor and anti-cancer agent., 20 (14): [PMID:22682301] [10.1016/j.bmc.2012.04.064] |
Source(1):